111 related articles for article (PubMed ID: 26759836)
1. Rational design and synthesis of substrate-product analogue inhibitors of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis.
Pal M; Khanal M; Marko R; Thirumalairajan S; Bearne SL
Chem Commun (Camb); 2016 Feb; 52(13):2740-3. PubMed ID: 26759836
[TBL] [Abstract][Full Text] [Related]
2. Potent dialkyl substrate-product analogue inhibitors and inactivators of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis by rational design.
Pal M; Easton NM; Yaphe H; Bearne SL
Bioorg Chem; 2018 Apr; 77():640-650. PubMed ID: 29502025
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
Carnell AJ; Kirk R; Smith M; McKenna S; Lian LY; Gibson R
ChemMedChem; 2013 Oct; 8(10):1643-7. PubMed ID: 23929631
[TBL] [Abstract][Full Text] [Related]
4. Novel 2-arylthiopropanoyl-CoA inhibitors of α-methylacyl-CoA racemase 1A (AMACR; P504S) as potential anti-prostate cancer agents.
Yevglevskis M; Nathubhai A; Wadda K; Lee GL; Al-Rawi S; Jiao T; Mitchell PJ; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Bioorg Chem; 2019 Nov; 92():103263. PubMed ID: 31536953
[TBL] [Abstract][Full Text] [Related]
5. Substrate-product analogue inhibitors of isoleucine 2-epimerase from Lactobacillus buchneri by rational design.
Sorbara NT; MacMillan JWM; McCluskey GD; Bearne SL
Org Biomol Chem; 2019 Sep; 17(37):8618-8627. PubMed ID: 31528932
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of serine and proline racemases by substrate-product analogues.
Harty M; Nagar M; Atkinson L; Legay CM; Derksen DJ; Bearne SL
Bioorg Med Chem Lett; 2014 Jan; 24(1):390-3. PubMed ID: 24314397
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary X-ray diffraction studies of an alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis.
Bhaumik P; Kursula P; Ratas V; Conzelmann E; Hiltunen JK; Schmitz W; Wierenga RK
Acta Crystallogr D Biol Crystallogr; 2003 Feb; 59(Pt 2):353-5. PubMed ID: 12554951
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mandelate racemase by the substrate-intermediate-product analogue 1,1-diphenyl-1-hydroxymethylphosphonate.
Burley RK; Bearne SL
Bioorg Med Chem Lett; 2005 Oct; 15(19):4342-4. PubMed ID: 16039120
[TBL] [Abstract][Full Text] [Related]
9. A novel colorimetric assay for α-methylacyl-CoA racemase 1A (AMACR; P504S) utilizing the elimination of 2,4-dinitrophenolate.
Yevglevskis M; Lee GL; Nathubhai A; Petrova YD; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Chem Commun (Camb); 2017 May; 53(37):5087-5090. PubMed ID: 28338138
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel small-molecule inhibitors of α-methylacyl-CoA racemase (AMACR; P504S) and structure-activity relationships.
Petrova YD; Wadda K; Nathubhai A; Yevglevskis M; Mitchell PJ; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Bioorg Chem; 2019 Nov; 92():103264. PubMed ID: 31536955
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and in vitro testing of alpha-methylacyl-CoA racemase inhibitors.
Carnell AJ; Hale I; Denis S; Wanders RJ; Isaacs WB; Wilson BA; Ferdinandusse S
J Med Chem; 2007 May; 50(11):2700-7. PubMed ID: 17477519
[TBL] [Abstract][Full Text] [Related]
12. The catalysis of the 1,1-proton transfer by alpha-methyl-acyl-CoA racemase is coupled to a movement of the fatty acyl moiety over a hydrophobic, methionine-rich surface.
Bhaumik P; Schmitz W; Hassinen A; Hiltunen JK; Conzelmann E; Wierenga RK
J Mol Biol; 2007 Apr; 367(4):1145-61. PubMed ID: 17320106
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of rationally designed AMACR 1A inhibitors.
Yevglevskis M; Lee GL; Nathubhai A; Petrova YD; James TD; Threadgill MD; Woodman TJ; Lloyd MD
Bioorg Chem; 2018 Sep; 79():145-154. PubMed ID: 29751320
[TBL] [Abstract][Full Text] [Related]
14. Alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis. Mutational and structural characterization of the active site and the fold.
Savolainen K; Bhaumik P; Schmitz W; Kotti TJ; Conzelmann E; Wierenga RK; Hiltunen JK
J Biol Chem; 2005 Apr; 280(13):12611-20. PubMed ID: 15632186
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of mandelate racemase by a fluorinated substrate-product analogue with a novel binding mode.
Nagar M; Lietzan AD; St Maurice M; Bearne SL
Biochemistry; 2014 Feb; 53(7):1169-78. PubMed ID: 24472022
[TBL] [Abstract][Full Text] [Related]
16. Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.
Bourque JR; Burley RK; Bearne SL
Bioorg Med Chem Lett; 2007 Jan; 17(1):105-8. PubMed ID: 17055725
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobic nature of the active site of mandelate racemase.
St Maurice M; Bearne SL
Biochemistry; 2004 Mar; 43(9):2524-32. PubMed ID: 14992589
[TBL] [Abstract][Full Text] [Related]
18. Expanding the chemical space of human serine racemase inhibitors.
Dellafiora L; Marchetti M; Spyrakis F; Orlandi V; Campanini B; Cruciani G; Cozzini P; Mozzarelli A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4297-303. PubMed ID: 26283510
[TBL] [Abstract][Full Text] [Related]
19. Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Marx A; Wandrey T; Simon P; Wewer A; Grob T; Reichelt U; Minner S; Simon R; Spehlmann M; Tigges W; Soehendra N; Seitz U; Seewald S; Izbicki JR; Yekebas E; Kaifi JT; Mirlacher M; Terracciano L; Fleischmann A; Raedler A; Sauter G
Hum Pathol; 2009 Feb; 40(2):166-73. PubMed ID: 18835622
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mandelate racemase by alpha-fluorobenzylphosphonates.
St Maurice M; Bearne SL; Lu W; Taylor SD
Bioorg Med Chem Lett; 2003 Jun; 13(12):2041-4. PubMed ID: 12781191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
